Stay updated with breaking news from Embecta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Embecta Corp. (NASDAQ:EMBC – Get Rating) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 3,050,000 shares, a decrease of 12.1% from the February 28th total of 3,470,000 shares. Based on an average daily trading volume, of 903,200 shares, the […]
WINTON GROUP Ltd acquired a new stake in Embecta Corp. (NASDAQ:EMBC – Get Rating) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 15,996 shares of the company’s stock, valued at approximately $461,000. A number of other institutional investors have also […]
Embecta Corp. is looking for acquisitions. Devdatt Kurdikar, Chief Executive Officer said during the Fiscal First Quarter 2023 Earnings Conference Call, "And finally, we also have our eye on the... | February 15, 2023
PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial
Nisa Investment Advisors LLC acquired a new position in shares of Embecta Corp. (NASDAQ:EMBC – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 25,731 shares of the company’s stock, valued at approximately $744,000. A number of other institutional investors […]